| scholarly article | Q13442814 |
| P356 | DOI | 10.1006/EXNR.2001.7755 |
| P698 | PubMed publication ID | 11573988 |
| P50 | author | Cecília Rodrigues | Q30421070 |
| Christopher Keene | Q73504518 | ||
| P2093 | author name string | Kren BT | |
| Steer CJ | |||
| Low WC | |||
| Eich T | |||
| Abt A | |||
| Linehan-Stieers C | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Huntington's disease | Q190564 |
| striatum | Q1319792 | ||
| P304 | page(s) | 351-360 | |
| P577 | publication date | 2001-10-01 | |
| P1433 | published in | Experimental Neurology | Q5421127 |
| P1476 | title | A bile acid protects against motor and cognitive deficits and reduces striatal degeneration in the 3-nitropropionic acid model of Huntington's disease | |
| P478 | volume | 171 |
| Q60895746 | 5. THE ROLE OF BILE ACIDS IN THE MODULATION OF APOPTOSIS |
| Q93182322 | A Stem Cell-Based Screening Platform Identifies Compounds that Desensitize Motor Neurons to Endoplasmic Reticulum Stress |
| Q37964359 | Antioxidants in Huntington's disease |
| Q47135121 | Bile Acid Signaling Pathways from the Enterohepatic Circulation to the Central Nervous System |
| Q28078549 | Bile Acids in Neurodegenerative Disorders |
| Q24653326 | Bile acids in treatment of ocular disease |
| Q24653969 | Bile acids: regulation of apoptosis by ursodeoxycholic acid |
| Q37157813 | Bile-acid-induced cell injury and protection |
| Q37071741 | Effect of a chemical chaperone, tauroursodeoxycholic acid, on HDM-induced allergic airway disease |
| Q37488273 | Emerging drug therapies in Huntington's disease |
| Q57760186 | Function of nuclear steroid receptors in apoptosis: role of ursodeoxycholic acid |
| Q57113939 | High Dose and Delayed Treatment with Bile Acids Ineffective in RML Prion-Infected Mice |
| Q48405759 | Lipid peroxidation is not the primary mechanism of bilirubin-induced neurologic dysfunction in jaundiced Gunn rat pups |
| Q47972723 | Mass spectrometry-based metabolomics: Targeting the crosstalk between gut microbiota and brain in neurodegenerative disorders |
| Q28217483 | Melatonin in Alzheimer's disease and other neurodegenerative disorders |
| Q38463278 | Mitochondria: Major Regulators of Neural Development |
| Q39014966 | Mitochondrial membrane fluidity is consistently increased in different models of Huntington disease: restorative effects of olesoxime |
| Q35540810 | Neuroprotective potential of escitalopram against behavioral, mitochondrial and oxidative dysfunction induced by 3-nitropropionic acid |
| Q52372755 | Neuroprotective strategies for retinal disease. |
| Q41351634 | No spatial memory deficit exists in Kunming mice that recently recovered from motor defects following 3-nitropropionic acid intoxication |
| Q92057319 | Novel serum metabolites associate with cognition phenotypes among Bogalusa Heart Study participants |
| Q37607467 | Protective Effect of Antioxidants on Neuronal Dysfunction and Plasticity in Huntington's Disease |
| Q52152147 | Role of Rho Kinase Inhibition in the Protective Effect of Fasudil and Simvastatin Against 3-Nitropropionic Acid-Induced Striatal Neurodegeneration and Mitochondrial Dysfunction in Rats. |
| Q30620946 | Synthesis and evaluation of water-soluble prodrugs of ursodeoxycholic acid (UDCA), an anti-apoptotic bile acid. |
| Q35797129 | TUDCA slows retinal degeneration in two different mouse models of retinitis pigmentosa and prevents obesity in Bardet-Biedl syndrome type 1 mice |
| Q48603223 | TUDCA, a bile acid, attenuates amyloid precursor protein processing and amyloid-β deposition in APP/PS1 mice. |
| Q57120659 | Tauroursodeoxycholic Acid Improves Motor Symptoms in a Mouse Model of Parkinson's Disease |
| Q34035789 | Tauroursodeoxycholic acid (TUDCA) protects photoreceptors from cell death after experimental retinal detachment |
| Q24649167 | Tauroursodeoxycholic acid preservation of photoreceptor structure and function in the rd10 mouse through postnatal day 30 |
| Q37384925 | Tauroursodeoxycholic acid prevents E22Q Alzheimer's Abeta toxicity in human cerebral endothelial cells. |
| Q54498834 | Tauroursodeoxycholic acid prevents MPTP-induced dopaminergic cell death in a mouse model of Parkinson's disease. |
| Q35022852 | Tauroursodeoxycholic acid reduces apoptosis and protects against neurological injury after acute hemorrhagic stroke in rats |
| Q34075502 | Tauroursodeoxycholic acid, a bile acid, is neuroprotective in a transgenic animal model of Huntington's disease. |
| Q92816765 | The Biosynthesis, Signaling, and Neurological Functions of Bile Acids |
| Q27026087 | The Unexpected Uses of Urso- and Tauroursodeoxycholic Acid in the Treatment of Non-liver Diseases |
| Q35515556 | Ursodeoxycholic Acid Ameliorates Apoptotic Cascade in the Rotenone Model of Parkinson's Disease: Modulation of Mitochondrial Perturbations. |
Search more.